Previous 10 | Next 10 |
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2019 on Wednesday, November 6, 2019, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eas...
A suite of three new liver ultrasound markers The latest addition to its new generation ultrasound portfolio: Aixplorer MACH 20 A symposium on new ultrasound markers for liver and breast AIX-EN-PROVENCE, France, Oct. 08, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI...
--World leader in breast cancer screening celebrates recent portfolio expansion to address the entire continuum of breast cancer diagnosis and care-- Hologic, Inc. (Nasdaq: HOLX) announced today that Steve MacMillan, the Company’s Chairman, President and Chief Executive Officer,...
Alexion Pharmaceuticals (NASDAQ: ALXN ) initiated with Outperform rating and $146 (45% upside) price target at William Blair. More news on: Alexion Pharmaceuticals, Inc., Change Healthcare Inc., Denali Therapeutics Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Futures Are Down, Why Are You Lavishing Such Praise On Powell? First of all, the futures are down just a bit at the time of this writing. If Powell performed badly, we'd be down significantly. I would not be surprised if the market closes flat or even up. Powell is praiseworthy for finessi...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 17 th Annual Global Healthcare Conference in New York, NY on Tuesday, September 10 at 12:20 p.m. Eastern Time. The presentation will be webcast live and may be accessed through a link on the ...
This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 08/14/2019. Please visit our " Tracking Larry Robbins’ Glenview Capital Manag...
The following slide deck was published by Hologic, Inc. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...